THE KPM GROUP DC LLC

Lobbying for REZOLUTE · clinical stage biopharmaceutical company creating therapies for metabolic diseases

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income · posted Oct 17, 2025

Bills named in this filing 1

Lobbying activity 1

Pharmacy

S.4426, Promising Pathway Act 2.0 (118th Congress)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.